← Open Payments lookup

CHRISTOPHER GAKWA: Open Payments

NPI 1205355831 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$699 in 35 payments from 10 companies in 2025. Trend: 2023 $133 · 2024 $154 · 2025 $699

Food & beverage: $699
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$208
Otsuka America Pharmaceutical, Inc.11$180
E.R. Squibb & Sons, L.L.C.5$101
ABBVIE INC.3$43
Janssen Pharmaceuticals, Inc2$38
Alkermes, Inc.2$31
Lundbeck LLC2$30
Takeda Pharmaceuticals U.S.A., Inc.1$30
Vanda Pharmaceuticals Inc.1$26
Teva Pharmaceuticals USA, Inc.1$14

Products named: INGREZZA, REXULTI, COBENFY, ABILIFY ASIMTUFII, VRAYLAR, INVEGA SUSTENNA, TRINTELLIX, FANAPT.

Industry payments across ID — which companies pay providers there.